These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 1905372

  • 21. [Therapy of brucellosis: clinical experience with a rifampicin- doxycycline combination].
    Montanari M, Gandini T, Torre D, Dietz A.
    Minerva Med; 1985 Jul 31; 76(30-31):1407-10. PubMed ID: 4022432
    [Abstract] [Full Text] [Related]

  • 22. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison.
    Carter JD, Valeriano J, Vasey FB.
    J Rheumatol; 2004 Oct 31; 31(10):1973-80. PubMed ID: 15468362
    [Abstract] [Full Text] [Related]

  • 23. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
    Sofian M, Velayati AA, Aghakhani A, McFarland W, Farazi AA, Banifazl M, Eslamifar A, Ramezani A.
    Scand J Infect Dis; 2014 Aug 31; 46(8):573-7. PubMed ID: 24934986
    [Abstract] [Full Text] [Related]

  • 24. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.
    Bayindir Y, Sonmez E, Aladag A, Buyukberber N.
    J Chemother; 2003 Oct 31; 15(5):466-71. PubMed ID: 14598939
    [Abstract] [Full Text] [Related]

  • 25. A multicenter therapeutic study of 1100 children with brucellosis.
    Lubani MM, Dudin KI, Sharda DC, Ndhar DS, Araj GF, Hafez HA, al-Saleh QA, Helin I, Salhi MM.
    Pediatr Infect Dis J; 1989 Feb 31; 8(2):75-8. PubMed ID: 2649867
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Treatment of brucellosis with rifampicin and doxycycline].
    Garcés JM, Verdaguer A, Gutiérrez-Cebollada J, Tàpies A, Drobnic L.
    Rev Clin Esp; 1987 Apr 31; 180(7):372-4. PubMed ID: 3602550
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hospital-based case series of 175 cases of serologically confirmed brucellosis in Bikaner.
    Kochar DK, Gupta BK, Gupta A, Kalla A, Nayak KC, Purohit SK.
    J Assoc Physicians India; 2007 Apr 31; 55():271-5. PubMed ID: 17694786
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
    Grilló MJ, De Miguel MJ, Muñoz PM, Marín CM, Ariza J, Blasco JM.
    J Antimicrob Chemother; 2006 Sep 31; 58(3):622-6. PubMed ID: 16849379
    [Abstract] [Full Text] [Related]

  • 31. A comparative study of therapeutic agents used for treatment of acute brucellosis.
    Feiz JM, Sabbaghian H, Sohrabi F.
    Br J Clin Pract; 1973 Nov 31; 27(11):410-3. PubMed ID: 4804270
    [No Abstract] [Full Text] [Related]

  • 32. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis.
    Montejo JM, Alberola I, Glez-Zarate P, Alvarez A, Alonso J, Canovas A, Aguirre C.
    Clin Infect Dis; 1993 May 31; 16(5):671-6. PubMed ID: 8507759
    [Abstract] [Full Text] [Related]

  • 33. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
    Vrioni G, Bourdakis A, Pappas G, Pitiriga V, Mavrouli M, Pournaras S, Tsakris A.
    Antimicrob Agents Chemother; 2014 Dec 31; 58(12):7541-4. PubMed ID: 25246401
    [Abstract] [Full Text] [Related]

  • 34. Lipid peroxidation levels in patients with acute brucellosis.
    Kilic N, Ozden M, Kalkan A.
    Clin Exp Med; 2005 Oct 31; 5(3):117-21. PubMed ID: 16284734
    [Abstract] [Full Text] [Related]

  • 35. Brucellosis in children of Dhofar Region, Oman.
    El-Amin EO, George L, Kutty NK, Sharma PP, Choithramani RS, Jhaveri VP, Salil P, Bedair SM.
    Saudi Med J; 2001 Jul 31; 22(7):610-5. PubMed ID: 11479644
    [Abstract] [Full Text] [Related]

  • 36. Epidemiological, clinical, biochemical, and treatment characteristics of brucellosis cases in Turkey.
    Arslan M, Ertunç B, Düz ME, Menekşe E, Avci BY, Avci E, Yilmaz G.
    J Infect Dev Ctries; 2024 Jul 29; 18(7):1066-1073. PubMed ID: 39078792
    [Abstract] [Full Text] [Related]

  • 37. [Evaluation of brucellosis patients in Trakya University Hospital].
    Aydoslu B, Celik AD, Kuloğlu F, Tansel O, Akata F, Tuğrul M.
    Mikrobiyol Bul; 2006 Jul 29; 40(3):257-63. PubMed ID: 17001856
    [Abstract] [Full Text] [Related]

  • 38. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.
    Cisneros JM, Viciana P, Colmenero J, Pachón J, Martinez C, Alarcón A.
    Antimicrob Agents Chemother; 1990 May 29; 34(5):881-3. PubMed ID: 2193624
    [Abstract] [Full Text] [Related]

  • 39. Doxycycline-rifampicin: physicians' inferior choice in brucellosis or how convenience reigns over science.
    Pappas G, Siozopoulou V, Akritidis N, Falagas ME.
    J Infect; 2007 May 29; 54(5):459-62. PubMed ID: 17070921
    [Abstract] [Full Text] [Related]

  • 40. [Thrombocytopenia cases due to acute brucellosis].
    Cesur S, Albayrak F, Ozdemir D, Kurt H, Sözen TH, Tekeli E.
    Mikrobiyol Bul; 2003 Jan 29; 37(1):71-3. PubMed ID: 12838681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.